<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000430882">
  <TermName>vascular endothelial growth factor receptor tyrosine kinase inhibitor</TermName>
  <TermPronunciation>(VAS-kyoo-ler EN-doh-THEE-lee-ul grothe FAK-ter reh-SEP-ter TY-ruh-seen KY-nays in-HIH-bih-ter)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance that blocks an enzyme needed to form blood vessels. Also called VEGFR tyrosine kinase inhibitor.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000713628" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;vascular endothelial growth factor receptor tyrosine kinase inhibitor&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000713627" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;inhibidor de la tirosina–cinasa del receptor del factor de crecimiento endotelial vascular&quot;" language="es" id="_7"/>
  <SpanishTermName>inhibidor de la tirosina–cinasa del receptor del factor de crecimiento endotelial vascular</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia que bloquea una enzima necesaria para la formación de vasos sanguíneos. También se llama inhibidor de la tirosina–cinasa del VEGFR, inhibidor de la tirosina–quinasa del receptor del factor de crecimiento endotelial vascular, inhibidor del dominio tirosina–cinasa del receptor del factor de crecimiento endotelial vascular e inhibidor del receptor tirosina–cinasa del factor de crecimiento endotelial vascular.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2005-05-23</DateFirstPublished>
  <DateLastModified>2008-01-15</DateLastModified>
</GlossaryTerm>
